期刊文献+

基层公立医院患者对药品带量采购政策认知的调查分析 被引量:3

Investigation on the Cognition of Patients to the Volume-based Procurement Policy in Primary Public Hospitals
下载PDF
导出
摘要 目的了解基层公立医院的患者对带量采购政策的态度、使用后的感受及影响患者对该政策感知及实际体会的影响因素,以期为后续政策的实施与推广提供基础依据和政策建议。方法设计调查问卷,对成都市5家基层公立医疗机构试点医院的患者进行调查,并运用SPSS软件对数据进行分析。结果共收集266份有效问卷,男性和女性分别占48.87%和51.13%。患者对带量采购政策的知晓率为56.77%;对带量采购政策的支持率为83.08%。有53.01%的受访者会因为药品价格低廉而担心药品质量;有76例(28.57%)服用过带量采购的药品,其中有50.00%的患者认为带量采购的药品与原来的同类药品相比疗效相差不大,同时59.21%的认为药物副作用方面“无差别”。68.42%的服药患者认为政策实行后总体医疗费用的下降程度明显降低。77.63%的用药患者遇见过缺药的情况,且与用药时间长短有关,差异有统计学意义(P<0.05)。结论药品带量采购政策施行效果较好,患者满意度较高;但是患者对政策的认知度有待提高,应加强宣传力度;公众对仿制药的质量信心不足。建议谨慎合理地制定药品价格,常态化抽检中选药品并及时公布检查结果。同时,需要各方加强沟通,完善制度,协商处理好缺药的问题。 OBJECTIVE To understand the attitude of patients on the policy of purchasing drugs with quantity,and their feelings after use,and the influencing factors of patients′perception and the practical experience of the policy,so as to provide the basis and suggestions for the implementation and promotion of the follow-up policy.METHODS A questionnaire was designed to investigate the patients,and the data were analyzed by SPSS software.RESULTS A total of 266 valid questionnaires were collected,48.87%of them were male and 51.13%were female.The awareness rate about the policy was 56.77%;83.08%of the respondents supported the policy.53.01%of them worried about the quality of drugs because of the low price;76 people(28.57%)had taken the volume-based procurement drugs.Among them,50%patients thought that the efficacy of the volume-based procurement drugs was not different from the non-volume-based procurement drugs,and 59.21%thought that there was“no difference”in the side effects.77.63%of the patients met the situation of drug shortage,and the longer the medication time,the higher the frequency,the difference was statistically significant(P<0.05).CONCLUSION At present,the implementation effect of the volume-based procurement policy is good,and the patients′satisfaction is high.However,patients′awareness of the policy needs to be improved,and publicity should be strengthened;The public lacks confidence in the quality of generic drugs.It is suggested that the price of drugs should be carefully and reasonably set,the selected drugs should be regularly sampled and the inspection results should be published in time,so as to enhance the public′s confidence in generic drugs.At the same time,all parties need to strengthen communication and negotiate to deal with the problem of drug shortage.
作者 陈海涛 陈学梁 贺晋豪 余静 阳丽 肖洁 昝旺 CHEN Hai-tao;CHEN Xue-liang;HE Jin-hao;YU Jing;YANG Li;XIAO Jie;ZAN Wang(Chengdu Qingbaijiang District People′s Hospital,Chengdu 610300,China;Chengdu Pidu District People′s Hospital,Chengdu 610599,China;The First People′s Hospital Of Longquanyi District,Chengdu 610100,China;Chengdu Xindu District People′s Hospital,Chengdu 610500,China;Chengdu Shuangliu District People′s Hospital,Chengdu 610200,China;Chengdu Medical College,Chengdu 610500,China)
出处 《海峡药学》 2022年第8期148-152,共5页 Strait Pharmaceutical Journal
基金 四川省基层卫生事业发展中心(项目编号:SWFZ20-Q-050)。
关键词 药品带量采购 公立医院改革 问卷调查 Volume-based procurement Reform of public hospitals Questionnaire survey
  • 相关文献

参考文献7

二级参考文献65

  • 1朱恒鹏.医疗体制弊端与药品定价扭曲[J].中国社会科学,2007(4):89-103. 被引量:178
  • 2Ortiz M, Simons LA, Calcino G. Generic substitution of commonly used medications: Australia-wide experience, 2007-2008 [J]. Med J Australia. 2010; 192(7): 370-3.
  • 3Kesselheim AS, Misono AS, Lee JL, et al. Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease A Systematic Review and Meta-analysis [J]. Jama-J Am Med Assoc. 2008; 300(21 ): 2514-26.
  • 4Carter BL. Equivalence of generic and brand-name drugs for cardiovascular disease [J]. JAMA. 2009; 301(16): 1654; author reply 5-6.
  • 5Howland RH. Are generic medications safe and effective [J]. J Psychosoc Nurs Ment Health Serv. 2010; 48(3): 13-6.
  • 6Chenu F, Batten LA, Zernig G, et al. Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study [J]. J Clin Psychiatry. 2009; 70(7): 958-66.
  • 7Del Tacca M, Pasqualetti G, Di Paolo A, et al. Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers [J]. Brit J Clin Pharmaco. 2009; 68( 1 ): 34-42.
  • 8Izuwa Y, Ueshima S, Sato T, et al. Frequency of decreased renal function between patients treated with brand and generic products of vancomycin hydrochloride injection [J]. Yakugaku Zasshi-Journal of the Pharmaceutical Society of,Japan. 2008; 128(10): 1493 -8.
  • 9Silva E, Diaz JA, Arias M J, et al. Comparative in vitro study of the antimicrobial activities of different commercial antibiotic products for intravenous administration [J]. BMC Clin Pharmacol. 2010; 10: 3.
  • 10Grima DT, Papaioannou A, Airia P, et al. Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study [J]. BMC Musculoskelet Disord. 2010:11:68.

共引文献162

同被引文献39

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部